Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel 2‐substituted thioquinazoline‐benzenesulfonamide derivatives as carbonic anhydrase inhibitors with potential anticancer activity
Heba T. Abdel‐Mohsen, Mohamed A. Omar, Andrea Petreni, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 12
Closed Access | Times Cited: 17

Showing 17 citing articles:

Identification of thienopyrimidine derivatives tethered with sulfonamide and other moieties as carbonic anhydrase inhibitors: Design, synthesis and anti-proliferative activity
Samah Higazy, Nermin Samir, Ahmed El‐Khouly, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107089-107089
Closed Access | Times Cited: 11
Recent Advances in Structural Optimization of Quinazoline-Based Protein Kinase Inhibitors for Cancer Therapy (2021–Present)
Heba T. Abdel‐Mohsen, Manal M. Anwar, Nesreen S. Ahmed, et al.
Molecules (2024) Vol. 29, Iss. 4, pp. 875-875
Open Access | Times Cited: 9
Benzimidazole‐oxindole hybrids: A novel class of selective dual CDK2 and GSK‐3β inhibitors of potent anticancer activity
Heba T. Abdel‐Mohsen, Yasmin M. Syam, Mahmoud S. Abd El‐Ghany, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 10
Closed Access | Times Cited: 8
A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: Design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments
Salma M. Hefny, Tarek F. El‐Moselhy, Nabaweya Sharaf El-Din, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116527-116527
Closed Access | Times Cited: 7
Quinazoline‐oxindole hybrids as angiokinase inhibitors and anticancer agents: Design, synthesis, biological evaluation, and molecular docking studies
Yasmin M. Syam, Somaia S. Abd El‐Karim, Heba T. Abdel‐Mohsen
Archiv der Pharmazie (2024) Vol. 357, Iss. 10
Closed Access | Times Cited: 7
Targeting carbonic anhydrases for the management of hypoxic metastatic tumors
Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 11, pp. 701-720
Closed Access | Times Cited: 17
Synthesis of new sulfonamide derivatives: Investigation of their interactions with carbonic anhydrase and cholinesterase enzymes by in vitro and in silico evaluations
Muhammet Gürkan Kurban, Reşit Çakmak, Eyüp Başaran, et al.
Journal of Molecular Structure (2024) Vol. 1314, pp. 138798-138798
Closed Access | Times Cited: 5
Rational design and synthesis of novel quinazolinone N-acetohydrazides as type II multi-kinase inhibitors and potential anticancer agents
Somaia S. Abd El‐Karim, Yasmin M. Syam, Ahmed M. El Kerdawy, et al.
Bioorganic Chemistry (2023) Vol. 142, pp. 106920-106920
Closed Access | Times Cited: 13
Diphenyl urea‐benzylidene acetohydrazide hybrids as fibroblast growth factor receptor 1 inhibitors and anticancer agents
Heba T. Abdel‐Mohsen, Amira M. Nageeb, Iman A. Y. Ghannam
Drug Development Research (2024) Vol. 85, Iss. 6
Closed Access | Times Cited: 4
Chemistry of heterocycles as carbonic anhydrase inhibitors: A pathway to novel research in medicinal chemistry review
Anjaneyulu Bendi, Taruna, Rajni Rajni, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 7
Closed Access | Times Cited: 3
Benzimidazole–dioxoisoindoline conjugates as dual VEGFR-2 and FGFR-1 inhibitors: design, synthesis, biological investigation, molecular docking studies and ADME predictions
Heba T. Abdel‐Mohsen, Amira M. Nageeb
RSC Advances (2024) Vol. 14, Iss. 39, pp. 28889-28903
Open Access | Times Cited: 3
The anticancer therapeutic potential of pyrimidine–sulfonamide hybrids
Peng Zhang, Congcong Shi, Tongbao Dong, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 9, pp. 905-924
Closed Access | Times Cited: 2
Oxindole–benzothiazole hybrids as CDK2 inhibitors and anticancer agents: design, synthesis and biological evaluation
Heba T. Abdel‐Mohsen
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Discovery of novel thioquinazoline-N-aryl-acetamide/N-arylacetohydrazide hybrids as anti-SARS-CoV-2 agents: Synthesis, in vitro biological evaluation, and molecular docking studies
Heba T. Abdel‐Mohsen, Mohamed A. Omar, Omnia Kutkat, et al.
Journal of Molecular Structure (2022) Vol. 1276, pp. 134690-134690
Open Access | Times Cited: 8
Novel benzenesulfonamide‐thiouracil conjugates with a flexible N‐ethyl acetamide linker as selective CA IX and CA XII inhibitors
Heba T. Abdel‐Mohsen, Ahmed M. El Kerdawy, Andrea Petreni, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 2
Closed Access | Times Cited: 5
Exploring heterocyclic scaffolds in carbonic anhydrase inhibition: a decade of structural and therapeutic insights
Nafeesa Naeem, Amina Sadiq, Mohamed I. A. Othman, et al.
RSC Advances (2024) Vol. 14, Iss. 48, pp. 35769-35970
Open Access
Synthesis, Anticancer Activity and Carbonic Anhydrase Inhibitory Activity of new Thiadiazole-hydrazone Derivatives
Hayrani Eren Bostancı, Ulviye Acar Çevik
Cumhuriyet Science Journal (2023) Vol. 44, Iss. 2, pp. 258-262
Open Access
Page 1

Scroll to top